인슐린 펜 시장 규모, 점유율, 성장 분석, 유형별, 최종 용도별, 지역별 - 산업별 예측(2024-2031년)

Global Insulin Pens Market size was valued at USD 6.2 billion in 2022 and is poised to grow from USD 7.73 billion in 2023 to USD 44.88 billion by 2031, growing at a CAGR of 24.6% during the forecast period (2024-2031).

The global insulin pens market is experiencing robust growth, driven by the rising prevalence of diabetes and the increasing adoption of insulin pens for their user-friendly and convenient delivery method. These pens are favored for their ease of use, precise dosing, and portability, particularly among the growing diabetic population in developing countries. Awareness of their benefits in diabetes management, alongside technological advancements-such as Bluetooth connectivity and data tracking features-has further propelled market expansion. However, challenges remain, including high costs of advanced models limiting accessibility in low-income regions, inadequate healthcare infrastructure in some areas, and regulatory complexities that manufacturers must navigate to ensure compliance with quality standards. Addressing these challenges is critical for sustained market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Insulin Pens market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Insulin Pens Market Segmental Analysis

Global Insulin Pens Market is segmented by Type, End-use, and region. Based on Type, the market is segmented into Reusable Insulin Pens, and Disposable Insulin Pens. Based on End-use, the market is segmented into Hospitals & Clinics, Homecare, and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Insulin Pens Market

The Global Insulin Pens market is significantly propelled by ongoing technological advancements within insulin pen devices. Innovations such as Bluetooth connectivity, built-in memory functions, and the emergence of smart insulin pens contribute to an enhanced user experience and more effective treatment outcomes. These modern features not only make it easier for patients to manage their diabetes but also promote adherence to treatment regimens. As patients increasingly seek devices that offer both convenience and functionality, these technological improvements are expected to fuel market growth, making insulin pens more appealing and accessible to a wider range of consumers.

Restraints in the Global Insulin Pens Market

The Global Insulin Pens market faces certain constraints primarily due to needle phobia and resistance among some individuals. This aversion to needles can significantly hinder the acceptance and utilization of insulin pens, as many people experience anxiety or fear associated with self-injection. Such apprehensions often lead to decreased adherence to treatment regimens and a preference for alternative methods of insulin delivery. Consequently, the presence of needle-related fears may result in an overall reluctance to adopt insulin pens, posing challenges for market growth and the effective management of diabetes among affected individuals.

Market Trends of the Global Insulin Pens Market

The Global Insulin Pens market is witnessing a significant trend towards customization and personalization, driven by the increasing demand for products that cater to individual patient needs. Manufacturers are responding by offering a variety of options, including a spectrum of colors, adjustable dose settings, and personalized branding features. This movement not only aims to enhance patient engagement and satisfaction but also fosters a sense of ownership among users, making insulin management more user-friendly. As awareness of diabetes continues to rise globally, the push for tailored solutions is expected to dominate the market, influencing product development and healthcare strategies in the coming years.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement
• Regulatory Landscape
• Patent Analysis
• Case Studies
• Customer & Buying Criteria Analysis

Global Insulin Pens Market Size by Type & CAGR (2024-2031)

• Market Overview
• Reusable Insulin Pens
• Disposable Insulin Pens

Global Insulin Pens Market Size by End-use & CAGR (2024-2031)

• Market Overview
• Hospitals & Clinics
• Homecare
• Others

Global Insulin Pens Market Size & CAGR (2024-2031)

• North America, (Type, End-use)
  • US
  • Canada
• Europe, (Type, End-use)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific, (Type, End-use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America, (Type, End-use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa, (Type, End-use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Novo Nordisk A/S
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly and Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ypsomed Holding AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BD (Becton, Dickinson and Company)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Owen Mumford Ltd
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Haselmeier AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Emperra GmbH E-Health Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Diamesco Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MANNKind Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jiangsu Delfu Medical Device Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pendiq GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sensile Medical AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Injex Pharma AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Copernicus Sp. z o.o.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Wockhardt Ltd
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation